Tubulointerstitial nephritis following high-dose ifosfamide in three breast cancer patients.
We report three cases of women with breast cancer who developed renal impairment following treatment with high-dose ifosfamide. All the women underwent renal biopsy, which demonstrated severe interstitial damage with tubular changes by light and electron microscopy. Although reversible acute tubular dysfunction is well recognised with ifosfamide therapy, the long-term outcome of ifosfamide-induced renal injury remains unclear. The results of the current study suggest that ifosfamide can cause severe irreversible renal tubulointerstitial injury and should be used with caution even when there is initially normal renal function.
Hill
P A
PA
Department of Anatomical Pathology, St Vincent's Hospital, Fitzroy, Victoria, Australia.
Prince
H M
HM
Power
D A
DA
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000473:pathology; D000075202:Contraindications; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D007684:Kidney Tubules / Q000187:drug effects* / Q000648:ultrastructure; D008854:Microscopy, Electron; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000473:pathology
D018906:Antineoplastic Agents, Alkylating; D007069:Ifosfamide